Organogenesis Holdings (ORGO) Inventory (2017 - 2026)

Organogenesis Holdings' Inventory history runs 10 years deep, the most recent figure standing at $28.4 million for Q1 2026.

• In Q1 2026, Inventory fell 3.11% year-over-year to $28.4 million; the TTM figure through Mar 2026 stood at $28.4 million (down 3.11% YoY), while the FY2025 annual figure was $29.6 million, up 13.0% from the prior year.
• Inventory was $28.4 million for Q1 2026 at Organogenesis Holdings, down from $29.6 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $39.6 million in Q3 2025 to a low of $22.7 million in Q1 2022.
• Historically, Inventory has averaged $27.7 million across 5 years, with a median of $27.0 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Inventory declined 23.5% in 2022, then jumped 46.41% in 2025.
• A 5-year view of Inventory shows it stood at $24.8 million in 2022, then climbed by 14.0% to $28.3 million in 2023, then dropped by 7.2% to $26.2 million in 2024, then advanced by 13.0% to $29.6 million in 2025, then fell by 4.06% to $28.4 million in 2026.
• The last three Inventory figures came in at $28.4 million (Q1 2026), $29.6 million (Q4 2025), and $39.6 million (Q3 2025), per Business Quant data.